Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carl Johan Lamm

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Statistics in Medicine|April 5, 2002
Coping with missing data in clinical trials: a model-based approach applied to asthma trialsJames Carpenter, Stuart Pocock, Carl Johan Lamm
Chest|August 28, 2009
The effects of inhaled budesonide on lung function in smokers and nonsmokers with mild persistent asthmaPaul M O'Byrne, Carl Johan Lamm, William W Busse, et al.
American Journal of Respiratory and Critical Care Medicine|November 8, 2008
Severe exacerbations and decline in lung function in asthmaPaul M O'Byrne, Søren Pedersen, Carl Johan Lamm, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|April 1, 2006
Cost-effectiveness of early intervention with once-daily budesonide in children with mild persistent asthma: results from the START studyKevin Weiss, Martin Buxton, Fredrik L Andersson, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|April 1, 2006
Early intervention of recent onset mild persistent asthma in children aged under 11 yrs: the Steroid Treatment As Regular Therapy in early asthma (START) trialYu-Zhi Chen, William W Busse, Søren Pedersen, et al.
Health and Quality of Life Outcomes|August 28, 2016
Association of knee pain and different definitions of knee osteoarthritis with health-related quality of life: a population-based cohort study in southern SwedenAliasghar A Kiadaliri, Carl Johan Lamm, Maria Gerhardsson de Verdier, et al.
The Journal of Allergy and Clinical Immunology|April 15, 2008
The Inhaled Steroid Treatment As Regular Therapy in Early Asthma (START) study 5-year follow-up: effectiveness of early intervention with budesonide in mild persistent asthmaWilliam W Busse, Søren Pedersen, Romain A Pauwels, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 26, 2013
Health-related quality of life of ticagrelor versus clopidogrel in patients with acute coronary syndromes-results from the PLATO trialLars-Åke Levin, Lars Wallentin, Lars Bernfort, et al.
The Journal of Allergy and Clinical Immunology|December 6, 2003
Cost-effectiveness analysis of early intervention with budesonide in mild persistent asthmaSean D Sullivan, Martin Buxton, L Fredrik Andersson, et al.
Lancet (London, England)|April 4, 2003
Early intervention with budesonide in mild persistent asthma: a randomised, double-blind trialRomain A Pauwels, Søren Pedersen, William W Busse, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Statistics in Medicine|April 5, 2002
Coping with missing data in clinical trials: a model-based approach applied to asthma trialsJames Carpenter, Stuart Pocock, Carl Johan Lamm
Chest|August 28, 2009
The effects of inhaled budesonide on lung function in smokers and nonsmokers with mild persistent asthmaPaul M O'Byrne, Carl Johan Lamm, William W Busse, et al.
American Journal of Respiratory and Critical Care Medicine|November 8, 2008
Severe exacerbations and decline in lung function in asthmaPaul M O'Byrne, Søren Pedersen, Carl Johan Lamm, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|April 1, 2006
Cost-effectiveness of early intervention with once-daily budesonide in children with mild persistent asthma: results from the START studyKevin Weiss, Martin Buxton, Fredrik L Andersson, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|April 1, 2006
Early intervention of recent onset mild persistent asthma in children aged under 11 yrs: the Steroid Treatment As Regular Therapy in early asthma (START) trialYu-Zhi Chen, William W Busse, Søren Pedersen, et al.
Health and Quality of Life Outcomes|August 28, 2016
Association of knee pain and different definitions of knee osteoarthritis with health-related quality of life: a population-based cohort study in southern SwedenAliasghar A Kiadaliri, Carl Johan Lamm, Maria Gerhardsson de Verdier, et al.
The Journal of Allergy and Clinical Immunology|April 15, 2008
The Inhaled Steroid Treatment As Regular Therapy in Early Asthma (START) study 5-year follow-up: effectiveness of early intervention with budesonide in mild persistent asthmaWilliam W Busse, Søren Pedersen, Romain A Pauwels, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 26, 2013
Health-related quality of life of ticagrelor versus clopidogrel in patients with acute coronary syndromes-results from the PLATO trialLars-Åke Levin, Lars Wallentin, Lars Bernfort, et al.
The Journal of Allergy and Clinical Immunology|December 6, 2003
Cost-effectiveness analysis of early intervention with budesonide in mild persistent asthmaSean D Sullivan, Martin Buxton, L Fredrik Andersson, et al.
Lancet (London, England)|April 4, 2003
Early intervention with budesonide in mild persistent asthma: a randomised, double-blind trialRomain A Pauwels, Søren Pedersen, William W Busse, et al.
Pageof 2